Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does APIXABAN Cause Heart failure with preserved ejection fraction? 21 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Heart failure with preserved ejection fraction have been filed in association with APIXABAN (ELIQUIS). This represents 0.0% of all adverse event reports for APIXABAN.

21
Reports of Heart failure with preserved ejection fraction with APIXABAN
0.0%
of all APIXABAN reports
0
Deaths
8
Hospitalizations

How Dangerous Is Heart failure with preserved ejection fraction From APIXABAN?

Of the 21 reports, 8 (38.1%) required hospitalization, and 1 (4.8%) were considered life-threatening.

Is Heart failure with preserved ejection fraction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 21 reports have been filed with the FAERS database.

What Other Side Effects Does APIXABAN Cause?

Death (18,501) Cerebrovascular accident (7,237) Atrial fibrillation (5,690) Off label use (5,590) Thrombosis (5,298) Fall (5,063) Cardiac disorder (4,917) Haemorrhage (4,770) Dyspnoea (4,379) Gastrointestinal haemorrhage (4,030)

What Other Drugs Cause Heart failure with preserved ejection fraction?

RITUXIMAB (66) CYCLOPHOSPHAMIDE (60) FUROSEMIDE (58) HYDROXYCHLOROQUINE (55) ALLOPURINOL (54) PANTOPRAZOLE (54) AZATHIOPRINE (48) CALCIUM (48) COLCHICINE (48) DARBEPOETIN ALFA (48)

Which APIXABAN Alternatives Have Lower Heart failure with preserved ejection fraction Risk?

APIXABAN vs APOMORPHINE APIXABAN vs APRACLONIDINE APIXABAN vs APREMILAST APIXABAN vs APREPITANT APIXABAN vs APROTININ

Related Pages

APIXABAN Full Profile All Heart failure with preserved ejection fraction Reports All Drugs Causing Heart failure with preserved ejection fraction APIXABAN Demographics